Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-02 8:43 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 19,306,283 49.900% | 3,091,758 (+19.07%) | View |
| 2023-12-20 4:35 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 16,214,525 49.900% | 3,865,687 (+31.30%) | View |
| 2023-09-19 4:15 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 12,348,838 49.900% | 8,679,260 (+236.52%) | View |
| 2023-03-13 4:18 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 3,669,578 32.700% | 824,135 (+28.96%) | View |
| 2023-01-12 4:46 pm Sale | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 2,845,443 27.800% | -68,290,626 (-96.00%) | View |
| 2022-11-18 4:30 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 71,136,069 28.400% | 4,008,924 (+5.97%) | View |
| 2021-11-26 4:45 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 67,127,145 31.100% | 67,127,145 (New Position) | View |